tiprankstipranks
Applied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
PremiumThe FlyApplied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
29d ago
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles
Premium
Company Announcements
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles
29d ago
Applied Therapeutics appoints Johnson as Executive Chairman, CEO steps down
Premium
The Fly
Applied Therapeutics appoints Johnson as Executive Chairman, CEO steps down
29d ago
Applied Therapeutics price target lowered to $5 from $14 at Baird
PremiumThe FlyApplied Therapeutics price target lowered to $5 from $14 at Baird
2M ago
Applied Therapeutics (APLT) Stock Plunges 75% as FDA Rules Against Genetic Drug
Premium
Market News
Applied Therapeutics (APLT) Stock Plunges 75% as FDA Rules Against Genetic Drug
2M ago
Applied Therapeutics target lowered to $8, ‘catalyst watch’ removed at Citi
Premium
The Fly
Applied Therapeutics target lowered to $8, ‘catalyst watch’ removed at Citi
2M ago
Applied Therapeutics CRL a ‘major setback,’ says William Blair
PremiumThe FlyApplied Therapeutics CRL a ‘major setback,’ says William Blair
2M ago
Applied Therapeutics downgraded to Sector Perform from Outperform at RBC
Premium
The Fly
Applied Therapeutics downgraded to Sector Perform from Outperform at RBC
2M ago
Applied Therapeutics down 84% after receiving CRL from FDA on NDA for govorestat
Premium
The Fly
Applied Therapeutics down 84% after receiving CRL from FDA on NDA for govorestat
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100